One drug that has been tearing up the newsfeed this year is abiraterone, a novel drug in phase II trials for prostate cancer. In February, data was presented at ASCO’s Genito-urinary satellite meeting that looked promising. Dr D.C. Danila and researchers from Memorial Sloan Kettering reported a small phase II trial in castration resistant metastatic [...]
Entries Tagged as 'abiraterone'
Abiraterone and prostate cancer
September 2nd, 2008 · No Comments · Cougar, abiraterone, biotechnology, cancer, competitive intelligence, oncology, pharma, prostate, strategy
Tags: